Prognostic Determinants Analysis and Nomogram for Bone Malignant Vascular Tumors: A Surveillance, Epidemiology and End Results (SEER) Analysis

10 July 2020 : Database Analysis

Sunli Hu^12ABCDEFG, Xiangyang Wang^1AB*

DOI: 10.12659/MSM.923305

Med Sci Monit 2020; 26:e923305

Related articles Order reprints Share article Share by email

View HTML version

Table 1 Patient characteristics and univariate analysis of prognostic factors affecting overall survival.

Characteristic		No (%) of patients	P
Age, y, mean±SD		58.45±19.15
Age group, y			0.000^*
	≥64	170 (76.5)
	<64	52 (23.5)
Sex			0.0255^*
	Male	138 (62.4)
	Female	83 (37.6)
Race/ethnicity			0.052
	White	185 (83.7)
	Black	23 (10.4)
	Other	13 (5.9)
Year of diagnosis			0.061
	1988–1995	33 (14.9)
	1996–2004	54 (24.4)
	2005–2015	134 (60.7)
Primary site			0.000^*
	Skull	17 (7.7)
	bones of the extremities	119 (53.8)
	Spine	62 (28.1)
	Bones of Body	9 (4.1)
	Other	14 (6.3)
Histologic type			0.000^*
	Angiosarcoma	130 (58.8)
	Hemangioendothelioma	28 (12.7)
	Epithelioid hemangioendotheliomas	45 (20.4)
	Hemangiopericytoma	18 (8.1)
Marital status			0.61
	Yes	180 (81.4)
	No	41 (18.6)
Radiation			0.173
	Yes	96 (43.4)
	No	125 (56.6)
Metastasis			0.000^*
	Yes	105 (39.5)
	No	132 (49.6)
	Unknow	29 (10.9)
Chemotherapy			0.108
	Yes	49 (22.2)
	No	172 (77.8)
Surgery			0.000^*
	Yes	130 (58.8)
	No	91 (41.2)
Grade			0.000^*
	I	20 (9.0)
	II	27 (12.2)
	III	36 (16.3)
	IV	63 (28.5)
	Unknow	75 (33.9)
^* Indicates statistical significance (p Skull – bone of skull and face and associated joints (includes mandible; bones of the extremities – bone, joint and articular cartilage of limbs; spines – vertebral column (includes sacrum and coccyx); bones of body – rib, sternum, clavicle and associated joint.

Back to the Article